Childhood pneumococcal diseases and serotypes: Can vaccines protect?

Indian Journal of Pediatrics

Volumn 77, Issue 12, 2010, Pages 1387-1391

  Hon, Kam Lun ^a   Ip, Margaret ^a   Lee, Kenneth ^a   Nelson, Edmund Anthony ^a   Shea, Ka Ho Eric ^a   Yuen, Yiu Sang Tony ^a   Leung, Ting Fan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibiotic resistance; Invasive S pneumoniae; Septicemia

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; PEDIATRIC WARD; PNEUMOCOCCAL INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INTENSIVE CARE; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES;

EID: 78651099226     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-010-0188-9     Document Type: Article

References (18)

1. Pneumococcal vaccines. WHO position paper. Weekly Epidemiological Record 1999; 74(23):177-83.
2. Ip M, Chau SS, Chi F, Cheuk ES, Ma H, Lai RW, et al. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin- susceptible and -nonsusceptible Streptococ-cus pneumoniae isolates in Hong Kong, 2000 to 2005. Antimicrob Agents Chemother. 2007;51(6):2192-4.
3. Ip M, Nelson EA, Cheuk ES, Sung RY, Li A, Ma H, et al. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong Kong. J Clin Microbiol. 2007;45(6):1969-71.
4. Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med. 2001;345(16):1177-83.
5. Kyaw MH, Jones IG, Campbell H. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: Their use globally could have a major impact on public health. Acta Paediatr. 2001;90(5):473-6.
6. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354(14):1455-63
7. Erratum appears in N Engl J Med. 2006 Aug 10;355[6]:638].
8. Musher DM. Pneumococcal vaccine-direct and indirect ("herd") effects. N Engl J Med. 2006;354(14):1522-4.
9. Morgenstern D, Garcia-Curiel CS. Clarifications about pneumococcal vaccines. Am J Health-Syst Pharm. 2010;67(3):183.
10. Ip M, Lyon DJ, Yung RW, Tsang L, Cheng AF. Introduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong Kong. J Clin Microbiol. 2002;40(4):1522-5.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Twentieth informational supplement, 20th ed. M100-S20. Clinical and Laboratory Standards Institute, Wayne, Pa.
12. O'Halloran DM, Cafferkey MT. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol. 2005;43(7):3487-90.
13. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298 (15):1772-8.
14. Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses- Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47(4):1012-20.
15. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63(3):511-9.
16. Hon KL, Hung E, Tang J, Chow CM, Leung TF, Cheung KL, et al. Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit. Pediatr Pulmonol. 2008;43(3):275-80.
17. Hon KL, Leung AK. Severe childhood respiratory viral infections. Adv Pediatr. 2009;56(1):47-73.
18. Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi- Pinto C, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol. 2010;39 Suppl 1:i172-85.